Literature DB >> 11681430

Usefulness of procalcitonin serum level for the diagnosis of bacteremia.

S Liaudat1, E Dayer, G Praz, J Bille, N Troillet.   

Abstract

The predictive value of procalcitonin serum levels to detect or rule out bacteremia was investigated prospectively in a case-control study with 200 hospitalized adults from whom blood samples were taken for culture. Fifty bacteremic patients (cases) had higher procalcitonin serum levels than the 150 controls with sterile blood cultures (11.7 vs. 0.7 ng/ml; P=0.0001), a difference that remained significant after controlling for potential confounders in multivariate analysis. At cut-off values of 0.5 and 0.2 ng/ml, the sensitivity of procalcitonin was 56 and 92%, and the specificity was 83 and 43%, respectively. These results yielded low positive (22 and 12%) and high negative predictive values (96 and 99%), reflecting primarily the low prevalence of bacteremia among patients who undergo blood cultures in hospitals (low pretest probability). Although caution is mandatory when using such markers at the individual level, procalcitonin, possibly together with other parameters, could nonetheless prove useful in future studies to rapidly rule out bacteremia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11681430     DOI: 10.1007/s100960100548

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

1.  Comparison of serum procalcitonin in respiratory infections and bloodstream infections.

Authors:  Yanhui Zhu; Yulin Yuan; Huayi Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Discriminative value of inflammatory biomarkers for suspected sepsis.

Authors:  Ephraim L Tsalik; L Brett Jaggers; Seth W Glickman; Raymond J Langley; Jennifer C van Velkinburgh; Lawrence P Park; Vance G Fowler; Charles B Cairns; Stephen F Kingsmore; Christopher W Woods
Journal:  J Emerg Med       Date:  2011-11-06       Impact factor: 1.484

3.  Blood cultures in ambulatory outpatients.

Authors:  Kevin B Laupland; Deirdre L Church; Daniel B Gregson
Journal:  BMC Infect Dis       Date:  2005-05-17       Impact factor: 3.090

4.  Does serum procalcitonin aid in the diagnosis of bloodstream infection regardless of whether patients exhibit the systemic inflammatory response syndrome?

Authors:  Rashi Arora; James P Campbell; Gyorgy Simon; Nishant Sahni
Journal:  Infection       Date:  2016-11-19       Impact factor: 3.553

5.  Sedimentation characteristics of leucocytes can predict bacteraemia in critical care patients.

Authors:  L Bogar; Z Molnar; P Kenyeres; P Tarsoly
Journal:  J Clin Pathol       Date:  2006-03-13       Impact factor: 3.411

Review 6.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

Review 7.  Pathophysiologic mechanisms in septic shock.

Authors:  Elizabeth G King; Gustavo J Bauzá; Juan R Mella; Daniel G Remick
Journal:  Lab Invest       Date:  2013-09-23       Impact factor: 5.662

8.  Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever.

Authors:  Myeong Hee Kim; Gayoung Lim; So Young Kang; Woo-In Lee; Jin-Tae Suh; Hee Joo Lee
Journal:  Yonsei Med J       Date:  2011-03       Impact factor: 2.759

9.  Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study.

Authors:  Cees van Nieuwkoop; Tobias N Bonten; Jan W van't Wout; Ed J Kuijper; Geert H Groeneveld; Martin J Becker; Ted Koster; G Hanke Wattel-Louis; Nathalie M Delfos; Hans C Ablij; Eliane M S Leyten; Jaap T van Dissel
Journal:  Crit Care       Date:  2010-11-17       Impact factor: 9.097

10.  Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis--a prospective, observational study.

Authors:  Axel Nierhaus; Stefanie Klatte; Jo Linssen; Nina M Eismann; Dominic Wichmann; Jörg Hedke; Stephan A Braune; Stefan Kluge
Journal:  BMC Immunol       Date:  2013-02-12       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.